Ocugen, Inc.
OCGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.17 | 0.06 | -0.10 | 4.71 |
| FCF Yield | -20.87% | -51.63% | -23.13% | -5.51% |
| EV / EBITDA | -3.64 | -1.67 | -2.35 | -13.71 |
| Quality | ||||
| ROIC | -87.33% | -136.43% | -109.83% | -58.28% |
| Gross Margin | 51.47% | 88.34% | 80.71% | 0.00% |
| Cash Conversion Ratio | 0.78 | 0.98 | 0.69 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.68% | – | 286.78% | – |
| Free Cash Flow Growth | 37.23% | -12.39% | -32.03% | -225.53% |
| Safety | ||||
| Net Debt / EBITDA | 0.49 | 0.50 | 0.80 | 1.58 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -734.53 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -786.94 | -1,644.57 | -6,130.48 | -1,432.73 |